Inventor · disambiguated record
Samuel Rose
Also filed as: ROSE SAMUEL · ROSE SAMUEL STEELE
6 granted patents·4 pending applications·124 citations·filing 1997–2024
82Inventor score
Top patents by PatentIndex Score
10 records- 0181US5816259AMethod for the diagnosis and treatment of cancer by the accumulation of radioactive precipitates in targeted cellsFiled 1997·Granted Oct 6, 1998·73 cites·36 claims
- 0269US6080383AMethod and composition for the treatment of cancer by the enzymatic conversion of soluble radioactive toxic agents into radioactive toxic precipitates in the cancerFiled 1997·Granted Jun 27, 2000·34 cites·86 claims
- 0368US7807136B2Method and composition for the treatment of cancer by the enzymatic conversion of soluble radioactive toxic precipitates in the cancerMAYERS GEORGE L·Filed 2004·Granted Oct 5, 2010·3 cites·2 claims
- 0459US2005113290A1Method and composition for treating cancer by converting soluble radioactive toxic agents into insoluble radioactive toxic precipitates via the action of non-mammalian enzymes bound to the non-endocytosing receptors of target cellsONCOLOGIC INC·Filed 2004·Application pending·0 cites
- 0558US6468503B2Method and composition for the treatment of cancer by the enzymatic conversion of soluble radioactive toxic precipitates in the cancerONCOLOGIC INC·Filed 1999·Granted Oct 22, 2002·14 cites·8 claims
- 0648US2003068382A1Method and composition for the treatment of cancer by the enzymatic conversion of soluble radioactive toxic agents into radioactive toxic precipitates in the cancerFiled 2002·Application pending·0 cites
- 0745US2011142756A1Method And Composition For The Treatment Of Cancer By The Enzymatic Conversion Of Soluble Radioactive Toxic Precipitates In The CancerMAYERS GEORGE L·Filed 2010·Application pending·0 cites
- 0840USPP36262P2Blueberry plant named ‘LB-1’ROSE SAMUEL STEELE·Filed 2024·Granted Nov 26, 2024·0 cites·1 claims
- 0936USPP36263P2Blueberry plant named ‘LB-30’ROSE SAMUEL STEELE·Filed 2024·Granted Nov 26, 2024·0 cites·1 claims
- 1028US2003045458A1Method and composition for treating cancer by converting soluble radioactive toxic agents into insoluble radioactive toxic precipitates via the action of non-mammalian enzymes bound to the non- endocytosing receptors of target cellsFiled 1997·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Samuel Rose files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →